Fungal infection can be both superficial and can also penetrate deep inside the body. They trigger the immune system causing inflammation or tissue damage. Both the topical treatment and drugs are used to treat these infections. This session deals with all those aspects related to fungal infections
The global antifungal drugs market size was valued at USD 11.3 billion in 2017. Raising prevalence of fungal infections such as Aspergillosis and Candidiasis is the key factor propelling the market. Global Antifungal Drugs Market is predicted to rise from 13,719 USD million in 2016 to 17,718 USD million by 2023. The industry is anticipated to register a CAGR of 3.7%, during the forecast period of 2017 - 2023.
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Vaccines and Immunizations Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Lower Respiratory and Pediatric IDs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Prevention and Control Public Health and Epidemiology Oral and Maxillofacial Infections Genomics and Infectious disease Special Session on COVID-19
Infection Control Conferences Immunology Conferences Immunization & Antibiotics Conferences Bacteriology Conferences HIV/AIDS conferences Mycology Conferences Biochemistry Conferences Sexually Transmitted Diseases Conferences Urinary Tract Infections Conferences Infection Conferences 2020 USA Bioinformatics Conferences Retroviruses Conferences Infectious Diseases Conferences Clinical Microbiology Conferences Tuberculosis Conferences